Announcement

Collapse
No announcement yet.

Vaccination adherence to influenza, pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Vaccination adherence to influenza, pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients


    Prim Care Diabetes. 2019 Sep 30. pii: S1751-9918(19)30327-4. doi: 10.1016/j.pcd.2019.09.004. [Epub ahead of print] Vaccination adherence to influenza, pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients.

    Moreno-Fernández J1, García-Seco JA2, Rodrigo EMO3, Segura AMS2, García-Seco F4, Muñoz-Rodríguez JR5.
    Author information

    1 Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. Electronic address: jmorenof@sescam.jccm.es. 2 Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. 3 Ciudad Real Medicine School, Castilla-La Mancha University, Ciudad Real, Spain. 4 Córdoba Medicine School, Córdoba University, Córdoba, Spain. 5 Translational Research Unit, Ciudad Real University Hospital, Ciudad Real, Spain.

    Abstract

    AIM:

    To document adherence to influenza, pneumococcal and hepatitis B virus (HBV) vaccination programme in adult type 1 diabetes mellitus (T1DM) patients.
    MATERIALS AND METHODS:

    Observational retrospective study using data obtained from computerized clinical records. We contacted all adult T1DM registered in our database from a tertiary diabetes care hospital. Primary efficacy outcome was to describe influenza, pneumococcal and HBV vaccination status.
    RESULTS:

    Three hundred patients were analyzed (male 53%). Mean age was 40.0±14.4years and T1DM duration was 19.7±11.8years. Thirty-five percent of the patients had complementary indications for studied vaccines. Adherence to vaccination program for influenza, pneumococcal and HBV was achieved by 55%, 18% and 17% of the patients, respectively. Only 3% of the subjects were vaccinated against the three microorganisms. Predictor of correct vaccination were: age, shorter diabetes duration, insulin pump treatment, better diabetes control and being a health professional. We detected 17 sick leaves, 127 lost working days and 3 hospitalizations due to flue during the follow-up.
    CONCLUSIONS:

    The uptake of recommended vaccinations against influenza, pneumococcal and HBV in adult T1DM patients was below desirable levels. A special effort is required to all health professionals to implement immunization among adult people with T1DM. Clinical Trials NCT03478254.
    Copyright © 2019 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.


    KEYWORDS:

    HBV; Influenza; Pneumococcal; Type 1 diabetes; Vaccination

    PMID: 31582202 DOI: 10.1016/j.pcd.2019.09.004

Working...
X